Published January 11, 2022
| Version v1
Dataset
Open
Virtual screening of the Janssen compound collection against SARS-CoV-2 Mpro
Description
This short report describes the most relevant results of virtually screening the Janssen Pharmaceutica compound collection for potential activity against SARS-CoV-2 Mpro and confirmation of potential hits in a VeroE6 cell-based anti-SARS-CoV-2 assay.
Files
Files
(60.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:84cdbbe3d040363cdc1bfc0b6de627e4
|
60.5 kB | Download |